Skip to main content
All lobbying clients

GLAXOSMITHKLINE, INC.

Lobbying client · District of Columbia · filed 2025 to 2026

Pharmaceutical Company

$2,730,000 Reported spend
62 Filings counted
11 Outside firms hired
4 Bills named

Spend is reported income plus in-house expenses across 62 filings. 2 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 11 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as GLAXOSMITHKLINE, GLAXOSMITHKLINE LLC, GLAXOSMITHKLINE, INC.

 Who filed for this client 11

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 4
  • H.R. 5376
    Impacts and Outcomes for Health Career Training Act
    7 filings
  • S. 705
    Innovation in Pediatric Drugs Act of 2025
    3 filings
  • H.R. 1
    One Big Beautiful Bill Act
    1 filing
  • S. 864
    HELP Copays Act
    1 filing
 Reported by year 2 years
  • 2026 $1,110,000 25 filings
  • 2025 $1,620,000 37 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 52
  • SENATE 52
  • Food & Drug Administration (FDA) 10
  • Health & Human Services, Dept of (HHS) 8
  • Centers For Medicare and Medicaid Services (CMS) 3
  • Executive Office of the President (EOP) 3
 Recent filings 64 total
Q3 report
SIMS STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $40,000 income · posted Oct 20, 2026
View →
Q3 report
MARSHALL & POPP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
TODD STRATEGY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
BGR GOVERNMENT AFFAIRS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
W STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · $40,000 income · posted Oct 19, 2026
View →
Q3 report
LMH STRATEGIC SOLUTIONS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
CAPITOL COUNSEL LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 18, 2026
View →
Q3 report
ALPINE GROUP PARTNERS, LLC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 16, 2026
View →
Q2 report
SIMS STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · Senate · $40,000 income · posted Jul 20, 2026
View →
Q2 report
TODD STRATEGY GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2 report
W STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · $40,000 income · posted Jul 20, 2026
View →
Q2 report
BGR GOVERNMENT AFFAIRS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2 report
ALPINE GROUP PARTNERS, LLC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 17, 2026
View →
Q2 report
MARSHALL & POPP, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 9, 2026
View →
Q2 report
CAPITOL COUNSEL LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 8, 2026
View →
Q2 report
LMH STRATEGIC SOLUTIONS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 5, 2026
View →
Q1 report
SIMS STRATEGIES, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · Senate · $40,000 income · posted Apr 20, 2026
View →
Q1 report
TODD STRATEGY GROUP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View →
Q1 report
W STRATEGIES, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · $40,000 income · posted Apr 20, 2026
View →
Q1 report
BGR GOVERNMENT AFFAIRS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View →

Showing the 20 most recent of 64 filings. Search the explorer for "GLAXOSMITHKLINE, INC.".

 Foreign entities disclosed 1
  • GSK PLC United Kingdom named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem